NXTCL.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:06):

Stats
Today's Volume	64 981.00
Average Volume	40 277.00
Market Cap	89.39M
EPS	SEK0 ( 2023-08-31 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-2.20
ATR14	SEK0.0780 (3.00%)

NextCell Pharma AB Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NextCell Pharma AB Financials

Annual	2023
Revenue:	SEK10.11M
Gross Profit:	SEK-884 834 (-8.75 %)
EPS:	SEK-1.160

Q4	2023
Revenue:	SEK2.83M
Gross Profit:	SEK112 724 (3.98 %)
EPS:	SEK-0.250

Q3	2023
Revenue:	SEK3.04M
Gross Profit:	SEK229 515 (7.55 %)
EPS:	SEK-0.320

Q2	2023
Revenue:	SEK2.11M
Gross Profit:	SEK-1.11M (-52.88 %)
EPS:	SEK-0.320

Financial Reports:

No articles found.

NextCell Pharma AB

NextCell Pharma AB, a biopharmaceutical company, engages in the research and development of novel stem cell therapies in Sweden. The company develops ProTrans, a drug candidate comprising stem cells primarily for treating autoimmune and inflammatory diseases. It also provides Cellaviva, a stem cell bank for the family-saving of stem cells from umbilical cord blood and umbilical cord tissue. NextCell Pharma AB was incorporated in 2014 and is based in Huddinge, Sweden.